Annual Conference Conference 2014 Keynote Speakers 2014 CSS 2014 Presentations & Posters Conference 2013 Keynote Speakers 2013 CSS 2013 Presentations & Posters Conference 2012 Keynotes 2012 CSS Conference 2012 CSS 2012 Presentations & Posters Conference 2011 Keynotes 2011 Conference 2010 Keynotes 2010 Conference 2009 Keynote 2009 Conference 2008 Keynote 2008 Conference 2007 Conference 2006 Conference 2005 Copenhagen, Denmark 2015 SDE Paris, France, 2015 SDE London, UK 2015 SDE New York, NY, USA 2015 SDE Chicago, Illinois, USA 2015 SDE Frankfurt, Germany 2015 SDE Mumbai, India 2015 SDE Frankfurt, Germany 2014 SDE Boston, MA 2014 SDE Durham, North Carolina 2014 SDE Basel, Switzerland 2014 SDE Copenhagen, Denmark 2014 SDE London, UK 2014 SDE Indianapolis, Indianna 2014 SDE Chennai and Pune, India 2014 SDE Bridgewater, New Jersey 2014 SDE Bangalore, India 2014 SDE Brussels, Belgium 2014 SDE Tokyo, Japan 2014 SDE San Francisco, California 2014 SDE Shanghai, China 2014 SDE SDE Basel 2013 SDE Beerse 2013 SDE Copenhagen 2013 SDE Frankfurt 2013 SDE Boston, MA 2013 SDE Durham, NC 2013 SDE Canton, MI 2013 SDE Redwood City CA 2013 SDE Wayne, PA 2013 SDE Hyderabad, India 2013 SDE Mumbai 2013 SDE Shanghai 2013 SDE Belgium 2012 SDE Denmark 2012 SDE New Jersey 2012 SDE California 2012 SDE Illinois 2012 SDE Switzerland 2012 SDE Germany 2012 SDE UK 2012 SDE Copenhagen 2011 SDE Brussels 2011 SDE Frankfurt 2011 SDE London 2011 SDE Philadelphia 2011 SDE San Francisco 2011 SDE North Carolina 2011 SDE Boston 2010 SDE Basel 2010 SDE Brussels 2010 SDE Copenhagen 2010 SDE London 2010 SDE Basel 2009 SDE Brussels 2009 SDE Frankfurt 2009 SDE London (CDISC) 2009 SDE London (PSI) 2009 SDE Middlesex (CDISC) 2008 GPP Membership Pharmaceutical Programming PhUSE Tube What is PhUSE PhUSE Wiki Newsletters 2015 SDEs Publications PhUSE Conference Archive Clinical Data Science Computational Science Symposium CS Working Groups PhUSE Tube Blog

Linked In Icon Twitter Icon Facebook Icon

"In a clear presentation it gave a perfect insight into our struggle with SDTM and legacy data"


Conference 2008 - Keynote Presentation

The major sections of the talk are listed below, but the supporting details, and how they are developed, make this a talk well worth viewing. 


Dr. Forster said that financial, macro-economic, political and technological forces are changing the face of the pharmaceutical industry and driving the need for pharmaceutical companies to adapt.

Forces discussed were:

  1. A shift away from the belief that bigger is better and Pharmaceutical companies are beginning to doubt that they will get “benefits of scale”.
  2. A slump in shareholder return that must be addressed if the pharmaceutical industry is to be the heavily invested industry that is has historically been.
  3. A historically short average patent life for Pharmaceutical products and this will soon create large financial pressures.
  4. R&D output (as measured by number of drugs approved) is flat but R&D spending is up.
  5. A decade of consolidation and consolidation has resulted in a shift in employment patterns.

Dr. Forster suggested that “in change, there is opportunity”  and discussed changes that he saw the industry making that were both positive and healthy.

Responses that the industry is making were:

  1. A shift to biologics and the resulting increase in a company’s ability to defend intellectual property.
  2. Greater outsourcing
  3. A shift in market focus from Europe an the US to emerging markets
  4. A shift away from “bigger is better” to new business models, especially in R&D.